Nanotechnology General News

The latest news from academia, regulators
research labs and other things of interest

Posted: Jan 16, 2014

Congress on Nanoengineering for Medicine and Biology to look at cancer in a new way

(Nanowerk News) Highlighting the integration of nano-based engineering and medicine, the ASME (American Society of Mechanical Engineers) 2014 3rd Global Congress on Nano-engineering for Medicine and Biology (NEMB 2014) will cover the latest programs in the research community to develop advanced devices for the detection and treatment of disease.

As NEMB 2014 prepares to open Feb. 2 in San Francisco, researchers are advancing the understanding of cancer beyond the popular theory that there exists one oncogene in a single cancer cell. A group of speakers at the conference will show that mechanical activity in the area around the tumor are key factors in understanding metastasis and devising treatment protocols.

Several plenary speeches at NEMB 2014 will explore the biochemical and mechanical signaling in tissue surrounding tumor cells that provides important scientific knowledge on the potential for cancerous growth – and the rate of that growth – in the patient.

These and other invited and participating speakers in the program will offer different perspectives on this theme, sharing research findings on the critical role of cellular communication, interaction, and movement in cancer and other biomedical investigations.

Biomimetic Materials to Control Cell Behaviors for Tissue Engineering and Regenerative Medicine, Jennifer West, Duke University

Continuing to Feb. 5 at the Westin St. Francis, NEMB 2014 will bring together leading researchers to assess the fundamental challenges in biology and medicine and explore the role of nanotechnology-based materials and devices in human health and rehabilitation.

Featuring 45 sessions, nine tracks, five tutorials, and a poster session, the three-day information exchange will include presentations from experts at research organizations that are forging new pathways in medical research and experimentation, including UC Berkeley, UC San Francisco, UC Davis, UC Irvine, UCLA, UC San Diego, University of Illinois at Urbana-Champaign, University of Minnesota, Purdue University, Harvard Medical School, Stanford University, and Massachusetts Institute of Technology.